Family · Pharmaceutical analytical standards
Bosentan
A dual endothelin receptor antagonist (ETA and ETB), approved in the United States in 2001: it is taken by mouth and used to treat pulmonary arterial hypertension. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Its target, endothelin, a powerful vasoconstrictor peptide made by the cells lining blood vessels, was only discovered in 1988 by Masashi Yanagisawa, then a graduate student at the University of Tsukuba.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
